Drug combo tested to shrink lung tumors before cancer surgery
NCT ID NCT07137390
Summary
This study aimed to test a two-drug combination (regorafenib and lorigerlimab) given before surgery to patients with colorectal cancer that had spread only to the lungs. The goal was to see if the treatment was safe and could shrink the lung tumors to make surgery more effective. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.